Universidad de Costa Rica
  • Sobre Kérwá
  • Acceso Abierto
  • Cómo Depositar
  • Políticas
  • Contacto
    • español
    • English
  • English 
    • español
    • English
  • Login
View Item 
  •   Kérwá Home
  • Investigación
  • Salud
  • Medicina, ciencias biomédicas y salud pública
  • View Item
  •   Kérwá Home
  • Investigación
  • Salud
  • Medicina, ciencias biomédicas y salud pública
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Recent treatment advances in HER2-positive metastatic breast cancer: a clinical approach

Artículo científico
View/Open
Artículo de revisión (983.2Kb)
Date
2012-05
Author
Verma, Sunil
Landaverde Recinos, Denis
Metadata
Show full item record
Abstract
The use of targeted therapy directed against HER2 is currently the standard of care in patients with metastatic HER2-positive breast cancer. The combination of trastuzumab with a taxane as first-line treatment in HER2-positive metastatic breast cancer patients is the most common therapeutic approach in this population. The combination of trastuzumab with other chemotherapeutic agents, including vinorelbine and capecitabine; and hormonal therapy agents, such as aromatase inhibitors, have also demonstrated significant activity, and may be considered as an option for selected patients. Recently, the addition of pertuzumab to trastuzumab and docetaxel in first-line therapy has demonstrated an increased progression-free survival in HER2-positive metastatic breast cancer patients. Novel strategies against HER2 in first-line treatment or after progression include HER tyrosine kinase inhibitors such as lapatinib in combination with either chemotherapy, aromatase inhibitors or trastuzumab. An increasing list of new compounds are currently under investigation, such as trastuzumab–emtansine, afatinib, everolimus and antiangiogenic agents, among others. This review discusses potential therapeutic approaches in the first-line setting and after progression beyond trastuzumab in metastatic breast cancer HER2-positive tumors based on the latest evidence.
URI
http://hdl.handle.net/10669/74769
External link to the item
10.2217/CPR.12.25
http://www.openaccessjournals.com/articles/recent-treatment-advances-in-her2positive-metastatic-breast-cancer-a-clinical-approach.pdf
Collections
  • Medicina, ciencias biomédicas y salud pública [1372]



  • Repositorios universitarios

  • Repositorio del SIBDI-UCR
  • Biblioteca Digital del CIICLA
  • Repositorio Documental Rafael Obregón Loría (CIHAC)
  • Biblioteca Digital Carlos Melendez (CIHAC)
  • Repositorio de Fotografías
  • Colección de videos de UPA-VAS
  • Sitios recomendados

  • Buscador regional de LA Referencia
  • Buscador del Open ROAR
  • Scientific Electronic Library Online (SciELO)
  • Directory of Open Access Journals (DOAJ)
  • Redalyc
  • Redes sociales

  • facebook.com/repositoriokerwa
  • @Ciencia_UCR
  • Sobre Kérwá
  • Acceso Abierto
  • Cómo depositar
  • Políticas
Contact Us | Send Feedback
Repositorio Institucional de la Universidad de Costa Rica. Algunos derechos reservados. Este repositorio funciona con DSpace.
Universidad de Costa Rica
 

 

Browse

All of KérwáCommunities & CollectionsTitlesAuthorsSubjectsProcedenceTypeThis CollectionTitlesAuthorsSubjectsProcedenceType

My Account

LoginRegister

  • Repositorios universitarios

  • Repositorio del SIBDI-UCR
  • Biblioteca Digital del CIICLA
  • Repositorio Documental Rafael Obregón Loría (CIHAC)
  • Biblioteca Digital Carlos Melendez (CIHAC)
  • Repositorio de Fotografías
  • Colección de videos de UPA-VAS
  • Sitios recomendados

  • Buscador regional de LA Referencia
  • Buscador del Open ROAR
  • Scientific Electronic Library Online (SciELO)
  • Directory of Open Access Journals (DOAJ)
  • Redalyc
  • Redes sociales

  • facebook.com/repositoriokerwa
  • @Ciencia_UCR
  • Sobre Kérwá
  • Acceso Abierto
  • Cómo depositar
  • Políticas
Contact Us | Send Feedback
Repositorio Institucional de la Universidad de Costa Rica. Algunos derechos reservados. Este repositorio funciona con DSpace.
Universidad de Costa Rica